Mutations in Norrin, the ligand of a receptor complex consisting of FZD4, LRP5 and TSPAN12, cause severe developmental blood vessel defects in the retina and progressive loss of the vascular system in the inner ear, which lead to congenital blindness and progressive hearing loss, respectively. We now examined molecular pathways involved in developmental retinal angiogenesis in a mouse model for Norrie disease. Comparison of morphometric parameters of the superficial retinal vascular plexus (SRVP), including the number of filopodia, vascular density and number of branch points together with inhibition of Notch signaling by using DAPT, suggest no direct link between Norrin and Notch signaling during formation of the SRVP. We noticed extensive vessel crossing within the SRVP, which might be a loss of Wnt-and MAP kinase-characteristic feature. In addition, endomucin was identified as a marker for central filopodia, which were aligned in a thornlike fashion at P9 in Norrin knockout (Ndp y/2 ) mice. We also observed elevated mural cell coverage in the SRVP of Ndp y/2 mice and explain it by an altered expression of PDGFb and its receptor (PDGFRb). In vivo cell proliferation assays revealed a reduced proliferation rate of isolectin B4-positive cells in the SRVP from Ndp y/2 mice at postnatal day 6 and a decreased mitogenic activity of mutant compared with the wildtype Norrin. Our results suggest that the delayed outgrowth of the SRVP and decreased angiogenic sprouting in Ndp y/2 mice are direct effects of the reduced proliferation of endothelial cells from the SRVP.
INTRODUCTION
Mutations in the human NDP (Norrie disease pseudoglioma) gene, encoding Norrin, cause congenital blindness, progressive deafness and mental retardation, a triad of symptoms characteristic for Norrie disease (ND) (1 -5) . Alternatively, mutations in NDP can exclusively lead to ocular symptoms in X-linked exudative vireoretinopathy (EVR) (6) , Coats' disease and retinopathy of prematurity (7, 8) . EVR is also caused by mutations in Frizzled-4 (FZD4, FZD4), low-density lipoprotein receptor-related protein 5 (LRP5, LRP5) or tetraspanin-12 (TSPAN12, TSPAN12) (9 -11) . Recessive mutations in LRP5 may also cause osteoporosis pseudoglioma syndrome (OPPG), which manifests with low bone mass in addition to the ocular phenotype in patients (OMIM: #259770). It has been shown in vitro that Norrin is a ligand for the canonical Wnt signaling receptor complex consisting of FZD4, LRP5 and TSPAN12 (12, 13) . Furthermore, the outgrowth of the superficial retinal vascular plexus (SRVP) from Ndp y/2 , Fzd4 2/2 , Lrp5 2/2 and Tspan12 2/2 is delayed and incomplete and all of these knockout mice lack the deep and intermediate retinal vascular plexuses (12) (13) (14) (15) (16) . We generated and examined a Norrin knockout mouse model (Ndp
) that resembles the human Norrie disease phenotype with respect to blindness and hearing loss (4, 14, 17) . Hyaloid vessels do not completely regress in Ndp y/2 , Fzd4 2/2 , Lrp5 2/2 and Tspan12 2/2 knockout mice (12 -14,16) . Retinal vascular hemorrhage and exudation from retinal blood vessels in Ndp knockout mice (Ndp y/2 ) are characteristic features. We previously demonstrated that expression of the plasmalemma vesicle-associated protein (PLVAP), which mediates vascular fenestration and promotes vascular leakiness, is highly † These two authors contributed equally. * To whom correspondence should be addressed at: Schorenstrasse (19) . The delayed outgrowth of the SRVP and the absence of deep sprouting could be caused either by defects in sprouting angiogenesis or by reduced proliferation of the SRVP. Sprouting angiogenesis is mediated by endothelial tip cells that guide the growing SRVP from the optic nerve head towards the retinal periphery along a vascular endothelial growth factor (VEGF) gradient (20) . Stalk cells following tip cells divide ensuring proliferation and growth. Thus, an imbalance of tip and stalk cells could lead to both observed effects. The proper differentiation of tip and stalk cells is mediated by a balanced expression and interaction of Notch1 with its ligands Dll4 and Jagged1 (21) (22) (23) (24, 25) .
Here, we focused on defects during development of the SRVP in Ndp y/2 mice. We quantified several vascular and angiogenic parameters and observed extensive vessel crossing within the SRVP which might be a MAPK-characteristic feature. We found reduced cell proliferation in the SRVP at the vascular front at P6 in Ndp y/2 mice which may explain the delayed outgrowth of the SRVP. We also detected elevated mural cell (MC) coverage of the SRVP starting at P9, which is consistent with previously found upregulation of Tie1, Pdgfb and Pdgfrb. Finally, we report for the first time endomucinpositive supernumerary central filopodia of the SRVP in Ndp y/2 retinas culminating at P9, the time point when the deep retinal vascular plexus (DRVP) normally would develop.
RESULTS

Vascular development in Norrin knockout mice
The wild-type mouse retina is avascular at birth and outgrowth of the SRVP progresses from the center towards the periphery from P1 until P8. Because the outgrowth of the SRVP is incomplete and delayed in Ndp y/2 mice (14), we hypothesized that there might be an imbalance between tip cell filopodia and/or adjacent stalk cell proliferation. We quantified the number of filopodia as well as the vascular density and number of branch points in the central plexus at the vascular front at P5 and P7 ( Fig. 1 ) (Supplementary Material, Table S1 ). The number of filopodia was significantly increased but the vascular density (Fig. 1A, C , E, G, I, K) and the number of branch points (Fig. 1A, C , E, G, J, L) were significantly decreased at P5 and P7 in Ndp y/2 mice. Moreover, filopodial protrusions in Ndp y/2 mice are straighter and expand with a narrower angle than filopodia of wild-type littermates ( Fig. 1O ) (Supplementary Material, Table S2 ). In contrast to the increased number of filopodia, the vascular front in general appears to be less ramified with a reduced amount of long tip cell protrusions (Fig. 1B and F) . (26, 27) . We compared our morphometric data from Norrin KO mice with published morphometric data from Jag1 iDEC mice and recognized delayed and incomplete outgrowth of the SRVP, together with a reduced vascular density and a decreased number of branch points in Jag1 iDEC and Ndp y/2 mice. In contrast to Ndp y/2 mice, the number of tip cell filopodia was reduced in Jag1 iDEC mice. Dll4 +/2 mice have an increased number of filopodia, increased number of branchpoints and a denser vascular SRVP. Hence, the Ndp y/2 phenotype of the SRVP displays as an intermingled picture, with a peripheral Jag1 gain of function but central Jag1 loss of function features. We asked the question whether or not Norrin is a negative regulator of Notch signaling. To answer this question, we examined the effect of Notch inhibition in Ndp y/2 mice in order to see if this may rescue the abnormal vascular development. We quantified and compared morphometric parameters in Norrin knockout and wild-type mice after inhibition of Notch signaling by injection of the g-secretase inhibitor DAPT (Fig. 2) . Administration of DAPT increased vascular density in wildtype and Ndp y/2 mice ( Fig. 2A-E) , while the number of filopodia only increased in wild-type but not in Ndp y/2 retinas ( Fig. 2F-J Table S3 ).
Comparison of vascular development in different mouse models
) (Supplementary Material,
Retinal EC proliferation in Norrin-deficient mice
To test the hypothesis if Norrin acts as a mitogen for cells in the SRVP, which would explain the reduced vascular density as well as the delayed and incomplete radial vascular outgrowth in Ndp y/2 mice, we quantified central EC proliferation after systemic bromodeoxyuridine (BrdU) injection and found significantly reduced proliferation rates of isolectin B4 (IB4)-positive ECs from the SRVP in Ndp y/2 mice at P6 (WT: ME + SD 101.71 + 16.54; KO: ME + SD 52.17 + 9.62; P-value: 1.8E25) (Fig. 3A and C) . The only exceptions from this observation are local hotspots of proliferation within bulky unorganized regions at the vascular front (Fig. 3D) . Additionally, we monitored the effect of Norrin on cell cycle progression in cell culture experiments by using an Fig. S1 ), which has been associated with the classic picture of Norrie disease (29) . HEK293T cells do not endogenously express Norrin, but were positive in RT -PCR for transcripts from FZD4, LRP5 and TSPAN12 (Supplementary Material, Fig. S1 ). Similarly to our BrdU data in Ndp y/2 mice, we found almost 6-fold increased cell cycle progression in cells that stably express human wild-type Norrin compared with cells that express the mutant Norrin isoform (Fig. 3F , Supplementary Material, Table S4 ).
Vascular remodeling in Norrin-deficient mice
Despite the reduced vascular outgrowth of the SRVP, we occasionally noticed bulky vascular areas at the front of Ndp y/2 mice, comprising three-dimensional accumulations of ECs (Fig. 4D ). To monitor vascular remodeling across the plexus, retinal whole-mounts were double stained for IB4 and collagen IV (ColIV). ColIV-positive tubes lacking IB4 staining represent empty basement membrane sleeves at positions where blood vessels have regressed (30, 31) . We noticed that vascular remodeling was elevated in Ndp y/2 mice at peripheral bulky vascular areas of the SRVP, but not in central areas (Fig. 4C, Fig. S3 ). ACs in Norrin knockout mice also interconnect less to the central plexus compared with the wild-type and instead grow further into the periphery (Fig. 6D ). At P21, disorganized twisted and tangled blood vessels form above the superficial plexus resembling fibrosis (Supplementary Material, Fig. S3t and w) . We hypothesized that A/V crossing could be caused by altered astrocyte -EC interaction and therefore co-stained astrocytes against PDGFRa and blood Junge et al.
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Benedito et al. Fig. S2 ). We did not observe an altered astrocytic network in Ndp y/2 retinas compared with wild-type and alignment between astrocytes and ECs was normal.
Mice lacking the Nrp1 cytoplasmatic domain or VEGF NES-CRE mice also show A/V crossing in the SRVP (24, 25) . This suggests that the loss of MAPK signaling might cause this phenotype. Therefore, we made use of our stably wild-type or p.C95R Norrin expressing HEK293T cell lines (Supplementary Material, Fig. S1 ) to monitor MAPK activity. We found a 1.9-fold increase in MAPK signaling in cells that express wild-type Norrin compared with those that expressed the mutant, disease-associated variant (Fig. 5I , Supplementary Material, Table S5 ).
Because of the above-described, strong SRVP phenotype in Ndp y/2 mice, it was crucial to examine whether the VCs and ACs exhibit characteristic molecular features of the respective vessel types. Retinal flatmounts were stained either for endomucin or for smooth muscle actin (SMA) at P7, P9, P12 and P21. In both, wild-type and Ndp y/2 mice, endomucin stained veins and venous portions while staining of arteries and arterioles was less intense (Fig. 6, Supplementary Material, Fig. S4 ) (32, 33) . Interestingly, the endomucin staining revealed supernumerary thorn-like assembled central filopodia around veins and capillaries of Ndp y/2 retinas ( Fig. 6D and E) . In contrast, capillary sprouts were much less abundant and, if present, much shorter in wild-type mice. Staining for the arterial and MC marker a-SMA in wild-type mice specifically labeled arteries at P7, P9 and P12 as well as arteries and large veins at P21. In Ndp y/2 retinas, arteries, veins and capillaries were covered with SMA-positive cells at P9, P12 and P21 (Fig. 7,  Supplementary Material, Fig. S5 ). Thus, MC recruitment to the SRVP is abnormally increased in Ndp y/2 retinas.
DISCUSSION
Deficiency of Norrin is known to cause Norrie disease, a severe X-linked recessive human disease characterized by congenital blindness, progressive hearing loss and, in some patients, mental retardation. We made use of a mouse model which mimics the human disease in eye and ear and applied morphometric analyses, Notch-inhibition by DAPT administration, as well as cell proliferation assays to characterize the angiogenic processes in the retina. We provide evidence that Norrin is a mitogenic stimulus for cells in the SRVP. Consistently, wild-type Norrin promotes E2F transcription factormediated cell cycle progression in a cell culture assay. Further, we identified endomucin as a marker for central filopodia, which were aligned in a thorn-like fashion at P9 in Ndp y/2 mice. Finally, we found aberrant vascular SMApositive MC coverage of veins and capillaries in the SRVP Human
in Ndp y/2 mice which indicates abnormally increased MC recruitment of the SRVP from Norrin KO mice.
Norrin and Notch signaling are not directly linked
We examined features of the SRVP in Ndp y/2 mice by quantifying and comparing morphometric parameters (Figs 1 and 2 , Supplementary Material, Tables S1 -S3) with published data from different mouse models with retinal vascular phenotypes ( Table 1) . We did not quantify later stages than P7 since the outgrowth of the superficial plexus in wild-type mice ends soon after this stage of development.
We noticed that the outgrowth of the SRVP is delayed in all mouse models ( DPax6 mice, while the deep plexus is present (Table 1) . We hypothesized that the canonical Wnt target gene Jag1 might link Norrin-Wnt and Notch signaling during development of the SRVP, since knocking out Ndp or Jag1 leads to aberrant SRVP development. However, we found significant differences in morphometric parameters between Ndp y/2 and Jag1 iDEC retinas, which are in conflict with this hypothesis. The number of filopodia was increased in Ndp y/2 and reduced Jag1 iDEC mice. Jag1 iDEC retinas also do not display defects in deep vascular development (22) which is a characteristic feature in Ndp y/2 retinas. All these phenotypic differences suggest that there is no direct link between Norrin-Wnt and Notch signaling via Jag1.
Inhibiting Notch signaling through systemic DAPT administration led to an increased vascular density in Ndp y/2 mice, but it did not reduce the supernumerary filopodia. Furthermore, vascular density increased similarly in wild-type and Ndp y/2 retinas after DAPT treatment, excluding a synergistic effect (Fig. 2E) . Accordingly, interaction effects were rejected by univariate analysis of variance (data not shown). Although the peripheral vascular network at the front is denser in DAPTtreated Ndp y/2 mice (Fig. 2D) , it still seems disorganized, three-dimensional and not planar. This implies that Notch inhibition can induce a peripheral hyper angiogenic response in Ndp y/2 mice but not re-establish normal vascular development. The diameter of the peripheral blood vessels increased, which might be due to involvement of Dll4-Notch signaling in A/V differentiation, leading to a more pronounced venous phenotype after DAPT injection and to an increase in vessel diameter ( Fig. 2A-D) . The number of filopodia significantly retinas upon DAPT administration (Fig. 2G, I , J).
Vascular remodeling in Norrin-deficient mice
We found enhanced vascular proliferation (Fig. 3) and also enhanced vascular regression/remodeling (Fig. 4) at the vascular bulky front in Ndp y/2 mice after BrdU injection and by co-staining of ColIV and IB4. We interpret the vessel regression of Ndp y/2 retinas as secondary effect which ensures a planar vascular plexus at positions where bulky vascular fronts were present before moving towards the periphery. Disorganized vascular fronts are also present in Fzd4 2/2 , Lrp5 2/2 and Tspan12 2/2 retinas (12,13,34). Further, we observed extensive crossing of arteries and veins (A/V) in Ndp y/2 retinas and we excluded an altered astrocytic scaffold to be the reason for these observations (Supplementary Material, Fig. S2 ).
Loss of Norrin signaling might alter MAPK signaling
A/V crossing is a feature of all Norrin-Wnt signaling deficient mice and also (12, 13, 16, 24, 25 ) the lack of the cytoplasmatic Figure 7 . Retinal veins and capillaries are abundantly covered by mural cells (MCs) in Ndp y/2 mice at P12. Retinal whole-mounts were co-stained with IB4 to label blood vessels (green) and against SMA to label arteries covered by MCs (red). Only arteries were covered by MCs in wild-type (WT) retinas. In contrast, arteries, veins and capillaries were covered by MCs in Ndp y/2 retinas (KO). a, artery; ac, arterial character; v, vein; vc, venous character. Scale bars ¼ 100 mm. ) or dosage-dependent reduction in neuronal VEGF-A paracrine signaling (VEGF-A NES-CRE ) lead to A/V crossing (24, 25) . The receptor pair consisting of VEGFR2 and Nrp1 triggers VEGF-mediated downstream MAPK signaling. Thus, the existence of A/V crossing in Ndp y/2 retinas and in retinas from VEGF-A NES-CRE and Nrp1 cytoD/D mice suggests that both pathways influence each other. Supporting this, Norrin-stimulated cells have elevated MAPK signaling activity compared with cells stimulated with mutant Norrin (Fig. 5I) . Similarly, we previously reported MAPK signaling to be the major pathway influenced by Norrin signaling according to transcriptome analyses using microarray data from Ndp y/2 retinas (18). Therefore, it will be intriguing to investigate the putative link between Norrin-Wnt and VEGF/Nrp1/MAPK signaling.
Norrin stimulates mitogenic activity in retinal ECs
Since the loss of Norrin leads to delayed and incomplete outgrowth of the SRVP, we analyzed the mitogenic activity of Norrin in mouse retinas and in cell culture using systemic BrdU injection and reporter assays, respectively. The reduced proliferation of IB4-positive ECs from the SRVP in Ndp y/2 retinas, as revealed after BrdU injection, indicates that Norrin might act as a mitogenic stimulus (Fig. 3) . Additionally, we monitored cell cycle progression by using the pE2F luciferase reporter construct. As expected, HEK293T cells, which endogenously express FZD4, LRP5 and TSPAN12 but not Norrin, and ectopically express human wild-type Norrin had an increased cell cycle progression compared with ectopically p.C95R mutant Norrin expressing cells (Fig. 3F) . Consistently, Ohlmann et al. (35) observed, by using a BrdU ELISA, that Norrin efficiently stimulates proliferation of human retinal microvascular ECs in vitro in a Wnt-dependent manner. Our findings together with the BrdU ELISA suggest that Norrin might act as a mitogenic stimulus on microvascular/capillary ECs of the SRVP (Fig. 3C) . This also can explain the delayed outgrowth of the SRVP. A key to understand the complexity of the retinal vascular phenotype in Ndp y/2 mice could be the differentiated view of events at the angiogenic front and within the central plexus. Transient peripheral phenomena like local hotspots of proliferation and remodeling, thickening of the vasculature and supernumerary filopodia could be interpreted as inability of vascular sprouts to escape the existing plexus. Hence, filopodia-projecting tip cells could be overrun by stalk cells, cluster and form the observed bulky areas. The supposed explanation for the Ndp y/2 superficial plexus phenotype is also supported by in silico models of vascular network formation. Travasso et al. (36) recently found, utilizing a mathematical model of sprouting angiogenesis, that low tip cell motility leads to a sparsely ramified plexus and increased stalk cell proliferation. Due to the lack of long tip cell protrusions projecting into the avascular space ahead of the vascular front, also characteristic for Ndp y/2 mice, stalk cells spend more angiogenic factors which decrease its concentrations and inhibits branching. The same study highlights that low overall EC proliferation also leads to reduced vessel ramification, corroborating our observations.
Veins and capillaries of Ndp y/2 retinas possess supernumerary central filopodia
To investigate the properties of ACs and VCs, we stained retinal whole-mounts against endomucin and SMA.
The surface of veins and capillaries in Ndp y/2 retinas was laced with endomucin-positive filopodia instead of being smooth and covered with none or very few filopodia as in control mice. The abundance of central filopodia peaks around P9, exactly when deep vascular sprouting in wild-type mice occurs. Interestingly, deep sprouting exclusively originates from venous vessels and capillaries but not from arteries. Therefore, it seems that veins and capillaries of the SRVP from Ndp y/2 retinas are able to create misaligned central filopodia. However, these filopodia might not be functional, since Ndp y/2 mice lack deep sprouting. It is also unclear which molecular mechanisms lead to those central supernumerary filopodia since published data focuses exclusively on the regulation of tip cell filopodia.
Veins and capillaries of Ndp y/2 retinas are excessively covered by MCs Staining of retinal blood vessels for SMA revealed extensive MC coverage of veins and capillaries from P9 onwards. This coverage persists at least till P21. We previously reported upregulation of PDGFb and PDGFRb within the same timeframe (14) . Interaction of all these genes regulates MC recruitment. Here, overexpression of PDGFb and its receptor (PDGFRb) could stimulate MC recruitment and the missing upregulation of Ang1 on MCs might prevent restriction of MC recruitment. Considering this as the likely mechanism of the excessive MC recruitment, we believe that this might be a response to vessel leakiness caused by upregulation of VEGF-A and PLVAP (14,18) due to hypoxia. Currently, it is unclear if this extensive MC recruitment goes along with a gain of AC in the affected veins and venules. If so, the gain in arterial or loss of VC could explain the disability to form the DRVP out of the SRVP from Ndp y/2 retinas, since deep sprouts emerge exclusively from venous vessels and capillaries of the SRVP (37) . The fact that we still can morphologically distinguish ACs and VCs and that we detected supernumerary endomucin-positive central filopodia on veins, venules and capillaries, but not on arteries, argues against a complete loss of the VC. However, the formation of uncoordinated central endomucin-positive filopodia at P9 and the excessive MC recruitment of venous vessels may indicate at least a partial loss of venous identity of the respective ECs with the consequence that central tip cells might develop, but being unable to induce proper deep sprouting.
The morphometric analysis together with results from the DAPT injections does not suggest a direct link between Norrin-Wnt and Notch signaling via Jag1. Our results suggest that Norrin is a mitogenic stimulus for IB4-positive ECs of the SRVP which explains its delayed outgrowth in Ndp y/2 mice. The A/V crossing occurs unlikely due to a disturbed astrocyte -EC interaction and it is unclear if the altered basal membrane of the SRVP contributes to this effect. We found that Norrin is able to stimulate MAPK signaling and also previously reported that MAPK signaling Human Molecular Genetics, 2012, Vol. 21, No. 12 2627 might be the primarily altered pathway in Norrin KO retinas. All this together with the A/V crossing phenotype suggests that MAPK signaling might be significantly altered in Norrin KO retinas. We also found excessive MC coverage of veins, venules and capillaries in Ndp y/2 retinas which might indicate a partial loss of venous identity but also contribute to the appearance of the altered basal lamina and possibly to the appearance of the thorn-like supernumerary central filopodia. Postnatal stages after P7 in mice mimic developmental stages from patients when hypoxia increases and leads to pathologic alterations of various retinal angiogenic maturation processes. These data are crucial for the investigation of related diseases, like familial exudative vitreoretinopathy or Coats' disease, with a less severe phenotype than Norrie disease, which have a realistic chance for the development of treatment regimens.
MATERIALS AND METHODS
Animals
Generation of the Ndp y/2 mouse line has been described elsewhere (4). The research was performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and was approved by the Veterinary Office of the State of Zurich (Switzerland).
Immunohistochemical staining
Retinas for whole-mount immunohistochemistry were fixed in 4% paraformaldehyde for 2 h or overnight at 48C. After fixation, retinas were blocked using 1 -10% normal goat or rabbit serum (VectorLabs) in PBST and subsequently incubated overnight with biotinylated IB4 (1:200; VectorLabs). The following primary antibodies were diluted in 1-5% serum in PBST and incubated over night: aSMA-CY3 (1:500; Sigma), ColIV (AbD serotec, 1:200), PDGFRa (R&D Systems, 1:500) and Endomucin (R&D Systems, 1:100). For secondary detection, Alexa Fluor streptavidin conjugates (Molecular Probes, 1:100) or anti-goat/rabbit Alexa Fluor-coupled secondary antibodies (Invitrogen, 1:500) were used. Retinas were washed five times with PBS, flat mounted and analyzed under bright-light illumination with a microscope (Axioplan 2, AxioCam HRc; Carl Zeiss) equipped with ApoTome (Carl Zeiss) or by confocal imaging using the CLSM Leica SP2 inverse microscope (Leica). The protocol from Pitulescu et al. (46) was used to stain for proliferating ECs (BrdU staining).
Image processing
Image J 1.44p (NIH) and Photoshop CS5 (Adobe) software were used for image processing. Overall image brightness was adjusted in a linear fashion on whole images if it was necessary to improve picture quality for prints. These adjustments did not influence interpretation and are in concert with suggestions for image processing in reference (38) . Results shown were obtained by performing at least two different independent experiments including at least four mutant or control animals per stage.
Morphometric analysis of retinal flatmounts
Each morphometric parameter was determined by averaging over four non-overlapping images per retina (one retina used per animal) with a minimum of four animals per group. Vascular density was determined by measuring the endothelial coverage per 300 × 300 mm field at the vascular front. The number of branch points was determined by counting vessel branch points within 300 × 300 mm fields. The number of filopodia at the vascular front within 68 × 51 mm fields was counted and normalized to 100 mm length of vasculature. BrdU-positive endothelial nuclei were counted in 424 × 317 mm fields at the vascular front and normalized to endothelial coverage within the same field (21) .
In vivo Notch inhibition
Notch signaling was inhibited by subcutaneous injection of 0.3 mg/g body weight N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butylester (DAPT, Merck) dissolved in 10% ethanol and 90% peanut oil. DAPT solution was injected twice at P5 and P6. Retinas were collected at P7. Control litters were injected with vehicle only. Seven litters were DAPT injected. Quantification of vascular density and number of filopodia in DAPT-treated versus untreated KO and WT mice were performed as described above (23) .
Quantification of Norrin-dependent proliferation and MAPK signaling in vitro
Stably wild-type or mutant p.C95R Norrin expressing HEK293T cells were used in these assays. Equal expression levels of wild-type and mutant Norrin were determined by western blot analysis (data not shown). To examine the proliferation rate or MAPK signaling activity, 8 × 10 4 cells/well of a 24-well plate were seeded and incubated at 378C/5% CO 2 overnight. Cells were transiently co-transfected with pE2F or pSRF firefly luciferase reporter and pRenilla constructs (SABiosciences) using the calcium precipitation method (39, 40) . Luciferase activity was measured using DualGloLuciferaseReporterAssaySystem (Promega). Firefly luciferase activity was normalized to co-transfected Renilla luciferase.
Statistical analysis
Statistical analysis was performed in SPSS 18.0 (IBM) using two-tailed unpaired Student's t-test.
Quantitative data from DAPT-injection experiments were processed with univariate analysis of variance with two independent variables. Avoiding bias due to unequal sample sizes, the estimated marginal means were calculated instead of arithmetically means. P-values below a ¼ 0.05 were considered significant.
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